Showing results (101-110 of 294) with videos related to

Sort By:
Pageof 30
International Journal of Cancer|April 12, 2021
Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: Case series and large-scale pharmacovigilance analysisDaria Maria Filippini, Milo Gatti, Vito Di Martino, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV statusCarlo Fallai, Federica Perrone, Lisa Licitra, et al.
Oncotarget|March 31, 2015
Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression dataLoris De Cecco, Monica Nicolau, Marco Giannoccaro, et al.
Future Oncology (London, England)|June 27, 2019
Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapyPaolo Bossi, Laura Botta, Paolo Bironzo, et al.
Expert Review of Anticancer Therapy|June 4, 2024
Adenoid Cystic carcinoma of minor salivary glands (AdCCmSG): a multidisciplinary updateRebecca Romanò, Francesca De Felice, Andrea Ferri, et al.
Future Oncology (London, England)|February 17, 2015
Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: an expert panel consensusKetty Peris, Lisa Licitra, Paolo A Ascierto, et al.
European Thyroid Journal|November 16, 2016
Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid CancerLars Bastholt, Michael C Kreissl, Dagmar Führer, et al.
Scientific Reports|April 24, 2024
MRI radiomics in head and neck cancer from reproducibility to combined approachesAnna Corti, Stefano Cavalieri, Giuseppina Calareso, et al.
Frontiers in Oncology|December 12, 2022
Salivary gland cancers in elderly patients: challenges and therapeutic strategiesElena Colombo, Charlotte Van Lierde, Alexandra Zlate, et al.
Pageof 30